Fig 2.
Control MR imaging examination, which was performed after 20 days of treatment, demonstrates regression in both nodular-enhancing lesions (the largest was 10 mm in diameter) in an axial T1-weighted contrast-enhanced sequence.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.